Search

everythinglearnresearchcommunity

for

Search:↓

Current treatments for Alopecia Areata don't fully meet patients' needs, indicating a need for better therapies.

Japanese patients and physicians often disagree on the severity of Alopecia Areata and treatment satisfaction, needing better communication and treatments.

Targeted immunotherapy could be a promising new treatment for hair regrowth.

The Middle East and Africa need better data, treatment consensus, and support for Alopecia Areata.

There are many treatments for common hair loss, but more trials are needed to decide which are best.

Baricitinib is a new, effective treatment for advanced alopecia areata but is costly and has risks.

Repurposing existing drugs for COVID-19 shows promise but requires more research to confirm effectiveness.

Azelaic acid cream can effectively treat scalp hair loss.

ILC1-like cells can cause alopecia areata by attacking hair follicles.

Getting insurance to cover the hair loss treatment tofacitinib is hard because it's not officially approved for that use.

Most patients with rheumatoid arthritis continued methotrexate treatment over two years, but those who stopped and restarted experienced more side effects and less improvement.

Changes in skin bacteria can affect hair loss and new treatments targeting these bacteria may prevent balding without sexual side effects.

The most common cause of hair loss in children is tinea capitis, followed by alopecia areata and telogen effluvium.

Up to half of people experience itchy scalp, often due to skin conditions like seborrheic dermatitis or psoriasis, and treatments vary based on the specific cause.

Sulfotransferase SULT1A1 activity may predict minoxidil treatment success for hair loss.

Skin stem cells help maintain skin health, grow hair, and heal wounds.

Drug repurposing is a cost-effective way to find new uses for existing drugs, speeding up treatment development.

MicroRNAs are important for skin health and could be targets for new skin disorder treatments.

Nucleic acids trigger chemokine production in skin cells, affecting skin inflammation.

Activating TRPV3 stops human hair growth.

The document concludes that understanding the genes and pathways involved in hair growth is crucial for developing treatments for hair diseases.

New treatments for immune disorders caused by FOXN1 deficiency are promising.

Underutilized seeds like jackfruit, Indian almond, and tamarind have valuable nutrients and compounds that can be used sustainably in various industries.

Multiomics helps understand and improve skin healing and repair.

COVID-19 is caused by a virus from bats, and efforts focus on prevention and treatment research.

Different types of skin stem cells can change and adapt, which is important for developing new treatments.

Radiotherapy can cause skin fibrosis, which is often overlooked and needs better treatment and evaluation.

Elderly skin care needs personalized treatment, early intervention, and integrated psychiatric care.

Tideglusib with hydrogel improves wound healing in rats.

Cornification is the process where living skin cells die to create a protective barrier, and problems with it can cause skin diseases.